Medicare Enrolled
Dr. Robert Sperry, MD
Optician · Bellingham, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sperry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sperry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sperry
Dr. Robert Sperry is an optician specialist in Bellingham, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sperry performed 4,102 Medicare services across 1,918 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sperry received a total of $4,025 from 26 pharmaceutical and/or device companies across 283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sperry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in WA
$4,025 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,102
Medicare services
Top 11% in WA for optician
1,918
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,260 | $18 | $48 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
466 | $86 | $309 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
325 | $8 | $14 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
219 | $10 | $22 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
187 | $13 | $33 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
184 | $6 | $14 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
120 | $4 | $9 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
116 | $10 | $22 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $56 | $218 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
109 | $1 | $4 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
99 | $3 | $7 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
98 | $131 | $314 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
85 | $12 | $66 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
78 | $6 | $13 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
77 | $5 | $12 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
74 | $16 | $38 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
61 | $2 | $5 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
48 | $9 | $20 |
| Hepatitis C antibody screening A blood test to check for antibodies indicating a Hepatitis C infection. This screening is performed for individuals at high risk or those with other covered indications. |
46 | $45 | $98 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
38 | $49 | $178 |
| PSA test (prostate cancer screening) | 38 | $18 | $41 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
38 | $11 | $62 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
35 | $19 | $41 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
30 | $94 | $305 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
24 | $8 | $18 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
21 | $4 | $25 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
18 | $35 | $166 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
16 | $4 | $10 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
16 | $7 | $26 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
14 | $15 | $34 |
| Drug test, instrument-assisted A laboratory test to detect the presence of drugs using an instrument for observation. |
13 | $16 | $36 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $101 | $431 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
11 | $283 | $698 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
11 | $31 | $63 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2023 ↗$4,025
Total received (2018-2023)
Avg $671/year across 6 years
Top 20% in WA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
283
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,025 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$102
2022
$24
2021
$17
2020
$403
2019
$1,631
2018
$1,848
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$102
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
AstraZeneca Pharmaceuticals LP
$756
Janssen Pharmaceuticals, Inc
$448
PFIZER INC.
$392
Lilly USA, LLC
$302
Novo Nordisk Inc
$274
Supernus Pharmaceuticals, Inc.
$256
Teva Pharmaceuticals USA, Inc.
$238
Amgen Inc.
$227
Boehringer Ingelheim Pharmaceuticals, Inc.
$221
GlaxoSmithKline, LLC.
$217
Medtronic, Inc.
$102
SANOFI-AVENTIS U.S. LLC
$101
Takeda Pharmaceuticals U.S.A., Inc.
$95
Allergan Inc.
$76
Abbott Laboratories
$48
Merck Sharp & Dohme Corporation
$46
Regeneron Healthcare Solutions, Inc.
$40
Novartis Pharmaceuticals Corporation
$40
Bioventus LLC
$30
Kowa Pharmaceuticals America, Inc.
$24
Radius Health, Inc.
$20
Astellas Pharma US Inc
$19
Gilead Sciences, Inc.
$17
Horizon Therapeutics plc
$13
Boston Scientific Corporation
$12
Otsuka America Pharmaceutical, Inc.
$11
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANORO · Aimovig · BASAGLAR · BEVESPI AEROSPHERE · BYSTOLIC · CHANTIX · Durolane · EMGALITY · ENTRESTO · FARXIGA · FORTEO · FreeStyle Libre · JANUVIA · JARDIANCE · KRYSTEXXA · LINZESS · LO LOESTRIN FE · LYRICA · Livalo · MYRBETRIQ · OXTELLAR XR · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Prolia · REXULTI · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Tresiba · Trintellix · Tymlos · VENASEAL · Victoza · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
140
Per 100K population
61.3
County median income
$80,989
Nearest hospital
ST JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sperry is a clinical cardiology specialist, with above-average Medicare volume (top 11% in WA), with low-engagement industry engagement in the top 20% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sperry experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sperry performed 1,260 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sperry receive payments from pharmaceutical companies?
Yes. Dr. Sperry received a total of $4,025 from 26 companies across 283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sperry's costs compare to other opticians in Bellingham?
Dr. Sperry's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sperry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Bellingham
Browse opticians in Bellingham ranked by procedure volume and transparency data.
Highest volume
Top Opticians in WA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in WA
Which WA opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology